JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Setting

Order Through VWR & Receive a FREE Sample

Support: [email protected]

Track Your Order

Home
Bioactive Compounds

Bioactive Compounds

A4146 CEP-33779
1 Citation

Summary: JAK2 inhibitor,highly selective

≥23.15 mg/mL
A4104 AR-42 (OSU-HDAC42)
2 Citation

Target: Histone Deacetylases (HDACs)

Summary: HDAC inhibitor,novel and potent

insoluble in EtOH; insoluble in H2O; ≥15.62 mg/mL
A4052 Doxycycline hyclate

Target: MMP

Summary: matrix metalloproteinases inhibitor

≥22.15 mg/mL
A4128 PF-03814735

Target: Aurora Kinases

Summary: Aurora A/B inhibitor

Soluble in DMSO
A4352 Anagrelide HCl

Summary: Thrombocytopenic agent

insoluble in EtOH; insoluble in H2O; ≥4.9 mg/mL
A3394 Epothilone D

Target: Microtubule/Tubulin

Summary: Natural polyketide compound

Soluble in DMSO
A8782 WM-1119

Summary: Inhibitor of KAT6A (MOZ) and KAT6B (MORF/QKF), anticancer, can be used in vivo

Soluble in DMSO
A1034 Acetyl Angiotensinogen (1-14), porcine

Summary: Angiotensinogen precursor

insoluble in EtOH; insoluble in H2O; ≥180.1 mg/mL
B8454 LY3200882

≥43.6 mg/mL
A1046 Dynamin inhibitory peptide

Summary: Peptide inhibitor of GTPase dynamin

≥112.1 mg/mL